Work

Faculty Opinions recommendation of Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.

Year: 2010

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.2261956.1878054

Authors: Jason Gotlib, Stephen Oh

Institutions: Stanford Medicine, Stanford Cancer Institute, Stanford University, Washington University in St. Louis

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4245128649

Cites:

Cited by:

Related to: 10